Dendritic Cell–T Cell Crosstalk as a Central Driver of Response and Resistance to Immune Checkpoint Therapies
<p>Dendritic cells (DCs) are emerging as central orchestrators of antitumor immunity, shaping the quality, magnitude, and persistence of T-cell responses within the tumor microenvironment. Growing evidence shows that successful immune checkpoint therapies (ICT) depend on highly coordinated DC–...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2026
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1242895 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Dendritic Cell–T Cell Crosstalk as a Central Driver of Response and Resistance to Immune Checkpoint Therapies
- Tolerogenic Dendritic Cells for Therapy of Immune-Mediated Inflammatory Diseases
- Role of Dendritic Cell Subsets on HIV-Specific Immunity
- Targeted Cancer Therapy by Dendritic Cell Vaccine
- Immune Checkpoint and Tumor Therapy
- Dendritic Cells in Atherogenesis: From Immune Shapers to Therapeutic Targets
- Immune and Cell Cycle Checkpoint Inhibitors for Cancer Immunotherapy